Cascadian Therapeutics Inc. (CASC): Seth Klarman Took A Victory Lap
Value investor Seth Klarman disclosed in a recent 13G filing that it tendered all of its 8.7 million stake in Cascadian Therapeutics Inc. (CASC).
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Ancora Advisors Frederick Disanto | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$64.30 | 42,636 | Large Shareholder | 26,868 | 2012-12-27 | Filing | |
$64.31 | 9,842 | Large Shareholder | 69,504 | 2012-12-26 | Filing | |
$64.28 | 5,465 | Large Shareholder | 79,346 | 2012-12-24 | Filing | |
$46.53 | 1,000 | Large Shareholder, Officer, Director | 124,359 | 2011-12-22 | Filing | |
$43.10 | 9,562 | Large Shareholder, Officer, Director | 125,359 | 2011-10-31 | Filing |